|
Accueil > Actualité
Pfizer: to present new data in hematology
(CercleFinance.com) - Pfizer will present its latest data, showcasing advances in the treatment of hemophilia, sickle cell disease and blood cancers at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH) in San Diego from 9 to 12 December.
The laboratory says that this data, from 39 presentations, represents continued innovation and progress in hemophilia, with crucial discoveries for Pfizer's new tissue factor pathway inhibitor (anti-TFPI) candidate, marstacimab, and the latest findings on an investigational next-generation treatment for sickle cell disease (SCD). Pfizer will also present the latest research on blood cancer, including Elrexfio (elranatamab-bcmm), a bispecific antibody approved by the Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory multiple myeloma. Copyright (c) 2023 CercleFinance.com. All rights reserved. |
30/05/2025 18:02
GE HealthCarede nouvelles directives recommandent Cerianna 30/05/2025 17:37 Aker Solutionscontrat de 2 GW pour BalWin2 en Allemagne 30/05/2025 17:08 Netflixle titre surperforme, BofA en renfort 30/05/2025 16:35 Pfizerla mortalité d'un cancer colorectal divisée par deux 30/05/2025 16:24 Alstomextension de la ligne 1 du métro de Kanpur, en Inde 30/05/2025 16:05 Solariasoutenu par un relèvement de broker Tous les articles sociétés |
